In vitro og in vivo undersøgelser har vist, at ritonavir i betydelig grad hæmmer CYP3A - og CYP2D6 - medierede biotransformationer.
In vitro and in vivo studies have demonstrated that ritonavir is a potent inhibitor of CYP3A- and CYP2D6- mediated biotransformations.